Amneal Pharmaceuticals Stock Price. Everything You Need To Know About The Amneal Pharmaceuticals Stock!
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. The company is headquartered in Bridgewater, New Jersey and currently employs 7,600 full-time employees. The company went IPO on 2009-03-16. The firm specializes in developing, manufacturing, marketing and distributing generic, injectables, biosimilars and branded specialty pharmaceutical products. Its segments include Generics, Specialty, and AvKARE. Its Generics segment includes approximately 250 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system (CNS) disorders, including Parkinson’s disease, and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Amneal Pharmaceuticals Stock Price. Everything You Need To Know About The Amneal Pharmaceuticals Stock! performance
- Employees 7600
- Company HQ Bridgewater
- Website https://www.amneal.com/
- AMRX Asset Type Common Stock
- AMRX Market Capitalization 1.9B
- Earnings Per Share -0.48
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.949
Are you looking to invest in the pharmaceutical industry? Consider Amneal Pharmaceuticals as a potential investment opportunity. Amneal Pharmaceuticals is a leading global pharmaceutical company that focuses on developing, manufacturing, and distributing high-quality generic and specialty pharmaceutical products. With a diversified portfolio of over 200 products, Amneal Pharmaceuticals is well-positioned in the market. Retail investors from Malaysia, Thailand, Indonesia, and Vietnam can easily invest in this stock through the investment platform provided by Zorion. With Zorion’s investment insights and recommendations, along with access to educational resources, investors can make informed decisions about investing in Amneal Pharmaceuticals. Take advantage of this opportunity to expand your investment portfolio.
